European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Metastatic and recurrent adenocarcinoma of the uterine cervix: a long-term survival of 16 years
1 Obstetrics and Gynaecology Department, De La Mujer Women’s Hospital/Virgen Del Rocio University Hospital, Seville (Spain)
2 Gynecologic Surgery Department, Mayo Clinic College of Medicine, Mayo Clinic, Phoenix, AZ
3 Gynecologic Oncology Department, University of Southern California, Los Angeles, CA (USA)
Eur. J. Gynaecol. Oncol. 2010, 31(3), 333–335;
Published: 10 June 2010
Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion:We conclude that longterm multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.